MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-PB-01-0027010
Macmillon Pharmaceuticals Private Limited - pharma in Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹83.91 Cr
▲ 50% YoY
Net profit · FY 2024
₹5.31 Cr
Net margin 6.3%
EBITDA · FY 2024
₹7.67 Cr
EBITDA margin 9.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹19.35 Lakh
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹4.59 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
363
Provident fund records
About Macmillon Pharmaceuticals Private Limited
Data last updated:
Macmillon Pharmaceuticals Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB1988PTC008661. Its GSTIN is 03AADCM3529J1ZM (Punjab). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹19.35 Lakh. It was formerly known as Macmillon Pharmaceuticals Ltd. It is led by directors including Asar Mohd Khan (Whole-Time Director) and Naresh Mahajan.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 62 63 Vijay Nagar Batala Road Amritsar, Punjab, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.91 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹5.31 Cr (net margin 6.3%) and EBITDA of ₹7.67 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 24% over five years.
The company has about 363 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ravenbhel Healthcare. As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹4.59 Cr on record. Court records list 20 cases involving the company, including 18 filed by the company and 2 filed against it; 6 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in March 2015. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Hema Pharmaceuticals Pvt Ltd with revenue of ₹85.23 Cr. The company has 3 MSME Form 1 returns on record between 2023 and 2024, listing 13 overdue payments to 7 micro and small suppliers.
Macmillon Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-01-0027010). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website macmillonpharma.com.
Company details
CIN U24231PB1988PTC008661
Registration Number 008661
Incorporation Date 08 September 1988
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-PB-01-0027010
CIN history
Macmillon Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231PB1988PTC008661, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231PB1988PTC008661 | Current |
| L24231PB1988PLC008661 | Previous |
| U24231PB1988PLC008661 | Previous |
Recognitions & Rankings of Macmillon Pharmaceuticals
Contact details
Macmillon Pharmaceuticals Private Limited's registered office is in Punjab. Its website is macmillonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address62 63 Vijay Nagar Batala Road Amritsar, Punjab, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Macmillon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Macmillon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Macmillon Pharmaceuticals operates one associated brand: Ravenbhel Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures drug formulations, offers contract development and exports pharmaceuticals globally. | ravenbhel.com |
Business activity
The main business activity of Macmillon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Macmillon Pharmaceuticals Private Limited, buy the company report.
Financials of Macmillon Pharmaceuticals Private Limited
FY 2024 filings availableMacmillon Pharmaceuticals Private Limited reported revenue of ₹83.91 Cr (up 50% YoY) for FY 2024.
Revenue · FY 2024
₹83.91 Cr ▲ 50%
Net profit · FY 2024
₹5.31 Cr margin 6.3%
EBITDA · FY 2024
₹7.67 Cr margin 9.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 39%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 68%
3 years · compounded
▲ 7%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 50% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹83.91 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Macmillon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Macmillon Pharmaceuticals Private Limited
Macmillon Pharmaceuticals has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Mahajan Also directs: Salutemlab Formulations Private Limited, Salutemlife Sciences Private Limited, Polycoatt Films Private Limited and 5 more | Director | 01 Apr 1996 | 30 Years 6 Months | Current |
| Satish Kumar | Director | 03 Oct 2017 | 9 Years 0 Months | Current |
| Sahil Mahajan Also directs: Salutemlab Formulations Private Limited, Salutemlife Sciences Private Limited, Polycoatt Films Private Limited and 5 more | Director | 01 Sep 2019 | 7 Years 1 Months | Current |
| Asar Mohd Khan | Whole-Time Director | 20 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Macmillon Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hema Pharmaceuticals Pvt Ltd | ₹85.23 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Sidmak Laboratories (India) Private Limited | ₹85.07 Cr (FY 2025) | -6.0% | Valsad, Gujarat, India | |||
| Nava Healthcare Private Limited | ₹84.21 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Macmillon Pharmaceuticals Private Limitedthis company | ₹83.91 Cr (FY 2024) | ₹5.31 Cr | 6.3% | 50.0% | 363 | Punjab, India |
| Sunbeam Lifesciences Private Limited | ₹83.83 Cr (FY 2025) | 25.0% | Puducherry, India | |||
| Curetech Formulations Private Limited | ₹83.74 Cr (FY 2024) | 4.0% | Himachal Pradesh, India | |||
| Wexford Laboratories Private Limited | ₹83.63 Cr (FY 2024) | 22.0% | Tumkur, Karnataka, India | |||
| Om Pharmaceuticals Limited | ₹83.53 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Brooks Laboratories Limited | ₹83.44 Cr (FY 2025) | 4.0% | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Macmillon Pharmaceuticals Private Limited, buy the company report.
Auditor
Macmillon Pharmaceuticals Private Limited is audited by P.C.MEHRA & CO. CHARTERED ACCOUNTANTS for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.C.MEHRA & CO. CHARTERED ACCOUNTANTS | FY 2024 | 000874N |
Shareholding
The shareholding of Macmillon Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Macmillon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
₹4.59 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jul 2011 | 10306697 | Bank of Baroda | ₹3 Cr | Open | |
| 24 Feb 2014 | 10484411 | Bank of Baroda | ₹34 Lakh | Satisfied | |
| 23 Dec 2013 | 10501415 | Bank of Baroda | ₹39 Lakh | Satisfied | |
| 31 May 2000 | 90182726 | Bank of Baroda | ₹1.78 Cr | Satisfied | |
| 14 Sep 1996 | 90179797 | Bank of Baroda | ₹25 Lakh | Satisfied |
To see the full charge records of Macmillon Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Macmillon Pharmaceuticals Private Limited has 5 deals on record (5 secondary share transfers); the latest was in March 2015.
Total deals
5
Secondary share transfers
5
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Sahil Mahajan Huf, 3 individuals Seller: 3 individuals |
| Dec 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| May 2013 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Apr 2012 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Macmillon Pharmaceuticals Private Limited has 20 court cases on record: 18 filed by Macmillon Pharmaceuticals, 2 filed against it. 6 cases are pending and 14 are disposed.
Total cases
20
Filed by the company
18
Filed against the company
2
Pending
6
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 0 | 5 |
| High courts | 8 | 2 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Mankind Pharma Ltd & Anr. | Disposed |
| District court, Amritsar, Punjab | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Amritsar, Punjab | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Amritsar, Punjab | Commercial suit | Filed by the company against M/S Arpit Medicare and 3 others | Pending |
| District court, Jammu, Jammu and Kashmir | Court case (Declaration Suit(Civil)) | Filed by the company against an individual | Pending |
To see the full case history of Macmillon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Macmillon Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 13 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Panchsheel Organics Limited | |||
| an individual supplier | |||
| Apsen Lifesciences | |||
| Venus Album Company Private Limited |
To see the full MSME payment records of Macmillon Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Macmillon Pharmaceuticals Private Limited has a workforce of 363 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
363
Active EPFO establishments
1
Employee growth
15.24%
GST
Macmillon Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCM3529J1ZM | Punjab | Active | 01 Jul 2017 |
| 01AADCM3529J1ZQ | Jammu and Kashmir | Active | 08 Jul 2017 |
To see the full GST registrations and return filing status of Macmillon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Macmillon Pharmaceuticals Private Limited has 12 board changes on record since 1996: 4 appointments and 8 cessations. The latest: Sahil Mahajan was appointed as Director on 01 Sep 2019.
AGM
Macmillon Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
Macmillon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge registered on 31 May 2000 via Charge ID 90182726 with Bank Of Baroda was fully satisfied on 01 Oct 2019.
Charges
A charge registered on 14 Sep 1996 via Charge ID 90179797 with Bank Of Baroda was fully satisfied on 01 Oct 2019.
Charges
A charge registered on 14 Sep 1996 via Charge ID 90182210 with Bank Of Baroda was fully satisfied on 01 Oct 2019.
Charges
A charge registered on 09 Aug 1996 via Charge ID 90179782 with Bank Of India was fully satisfied on 01 Oct 2019.
Charges
A charge registered on 09 Aug 1996 via Charge ID 90182201 with Bank Of Baroda was fully satisfied on 01 Oct 2019.
Appointed
Sahil Mahajan was appointed as Director.
Ceased
Naresh Mahajan ceased to be Managing Director.
Ceased
Satish Kumar ceased to be Additional Director.
Ceased
Sahil Mahajan ceased to be Director.
Appointed
Satish Kumar was appointed as Director.
23 earlier events are in the company report.
Frequently asked questions
Macmillon Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 1988 (38+ years old) and is registered under CIN U24231PB1988PTC008661.
Macmillon Pharmaceuticals has 4 current directors:
- Asar Mohd Khan - Whole-Time Director
- Naresh Mahajan - Director
- Satish Kumar - Director
- Sahil Mahajan - Director
The latest financial statements of Macmillon Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Macmillon Pharmaceuticals is 03AADCM3529J1ZM, registered in Punjab. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 01AADCM3529J1ZQ (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Macmillon Pharmaceuticals is U24231PB1988PTC008661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Macmillon Pharmaceuticals has 20 court cases on record: 18 filed by the company and 2 filed against it. 6 are pending. Most are in the district courts.
Macmillon Pharmaceuticals was incorporated on 08 September 1988, making it 38+ years old. It is registered with the Registrar of Companies, Chandigarh.
Macmillon Pharmaceuticals has 5 deals on record (5 secondary share transfers); the latest was in March 2015.
The peers of Macmillon Pharmaceuticals by revenue are Hema Pharmaceuticals Pvt Ltd, Sidmak Laboratories (India) Private Limited, Nava Healthcare Private Limited, Inchem Laboratories Private Limited, Sunbeam Lifesciences Private Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sahil Mahajan was appointed as Director on 01 Sep 2019. Naresh Mahajan ceased to be Managing Director on 31 Mar 2019. Satish Kumar ceased to be Additional Director on 29 Sep 2018. Macmillon Pharmaceuticals has 12 board changes on record in total.
Yes, Macmillon Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-PB-01-0027010).
Macmillon Pharmaceuticals has 3 MSME Form 1 returns on record between 2023 and 2024, listing 13 overdue payments to 7 micro and small suppliers. The latest return was filed on 29 Apr 2024.